The Valley Desk

NCT04791319 · Interventional trial

A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis

Overall registry status Terminated

Phase 2

Conditions Dermatitis, Atopic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov